Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT03651154
NA

Hypovolemic Phlebotomy to Reduce Blood Transfusions in Major Hepatic Resections

Sponsor: Ottawa Hospital Research Institute

View on ClinicalTrials.gov

Summary

Major liver resection is associated with substantial intraoperative blood loss and subsequently blood transfusions. Blood transfusion in elective liver surgery is a significant factor of perioperative morbidity and mortality, as well as possibly long-term oncologic outcome. The purpose of this study is to use whole blood phlebotomy to decrease the central venous pressure, resulting in a state of relative hypovolemia. It is hypothesized that this intervention will lead to a decrease in blood loss at the time of liver resection and thus reduced blood transfusion in major liver surgeries.

Official title: PRICE 2: A Phase 3 Randomized Controlled Trial of Phlebotomy Resulting in Controlled Hypovolemia to Prevent Blood Loss in Major Hepatic Resections

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

440

Start Date

2018-09-28

Completion Date

2026-01

Last Updated

2025-07-31

Healthy Volunteers

No

Interventions

PROCEDURE

Hypovolemic Phlebotomy

Removal of 7-10ml/kg of blood from participant, as tolerated after patient is under anesthesia, before liver resection start time

Locations (4)

Vancouver General Hospital

Vancouver, British Columbia, Canada

The Ottawa Hospital

Ottawa, Ontario, Canada

Centre Hospitalier de l"Université de Sherbrooke

Montreal, Quebec, Canada

Centre Hospitalier de l'Université de Montréal

Montreal, Quebec, Canada